A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Clinical trial NCT02902809 · TERMINATED

Trial details

NCT number: NCT02902809
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Inadequately Controlled Asthma

Start date: 2016-11-11
Primary completion: 2018-01-19
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.